Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Thorax|July 15, 2020
Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control studyMichael J Abramson, Tsitsi Murambadoro, Sheikh M Alif, et al.
The Journal of Investigative Dermatology|June 5, 2021
Polygenic Risk Scores Stratify Keratinocyte Cancer Risk among Solid Organ Transplant Recipients with Chronic Immunosuppression in a High Ultraviolet Radiation EnvironmentMathias Seviiri, Matthew H Law, Jue Sheng Ong, et al.
Archives of Dermatological Research|September 5, 2020
Destructive and topical treatments of skin lesions in organ transplant recipients and relation to skin cancerAdele C Green, Mandy Way, Mariella Oster, et al.
The Lancet. Respiratory Medicine|February 23, 2016
Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trialFelix J F Herth, Arschang Valipour, Pallav L Shah, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 12, 2015
International Society for Heart and Lung Transplantation Donation After Circulatory Death Registry ReportMarcelo Cypel, Bronwyn Levvey, Dirk Van Raemdonck, et al.
Thorax|March 22, 2023
Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trialAlex West, Nazia Chaudhuri, Adam Barczyk, et al.
Respirology (Carlton, Vic.)|March 30, 2019
Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testingAndrew Burgess, Ken Goon, John D Brannan, et al.
Respirology (Carlton, Vic.)|August 29, 2017
Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation AustraliaHelen E Jo, Lauren K Troy, Gregory Keir, et al.
Respirology (Carlton, Vic.)|July 11, 2023
Long-term exposure to low concentrations of air pollution and decline in lung function in people with idiopathic pulmonary fibrosis: Evidence from AustraliaQiang Zheng, Ingrid A Cox, Lucy Leigh, et al.
BMJ Open Respiratory Research|December 3, 2021
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosisJohn A Mackintosh, Maria Pietsch, Viviana Lutzky, et al.
Pageof 7